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Hypoxia attenuates effector-target cell interaction in the airway
and pulmonary vascular compartment
Abstract
Leucocyte infiltration is known to play an important role in hypoxia-induced tissue damage. However,
little information is available about hypoxia and interaction of effector (neutrophils) with target cells
(alveolar epithelial cells, AEC; rat pulmonary artery endothelial cells, RPAEC). The goal of this study
was to elucidate hypoxia-induced changes of effector-target cell interaction. AEC and RPAEC were
exposed to 5% oxygen for 2-6 h. Intercellular adhesion molecule-1 (ICAM-1) expression was
determined and cell adherence as well as cytotoxicity assays were performed. Nitric oxide and heat
shock protein 70 (HSP70) production was assessed in target cells. Under hypoxic conditions enhanced
ICAM-1 production was found in both cell types. This resulted in an increase of adherent neutrophils to
AEC and RPAEC. The death rate of hypoxia-exposed target cells decreased significantly in comparison
to control cells. Nitric oxide (NO) concentration was enhanced, as was production of HSP70 in AEC.
Blocking NO production in target cells resulted in increased cytotoxicity in AEC and RPAEC. This
study shows for the first time that target cells are more resistant to effector cells under hypoxia,
suggesting hypoxia-induced cell protection. An underlying mechanism for this phenomenon might be
the protective effect of increased levels of NO in target cells.
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Summary
Leucocyte infiltration is known to play an important role in hypoxia-induced
tissue damage. However, little information is available about hypoxia and
interaction of effector (neutrophils) with target cells (alveolar epithelial cells,
AEC; rat pulmonary artery endothelial cells, RPAEC). The goal of this study
was to elucidate hypoxia-induced changes of effector–target cell interaction.
AEC and RPAEC were exposed to 5% oxygen for 2–6 h. Intercellular adhesion
molecule-1 (ICAM-1) expression was determined and cell adherence as well as
cytotoxicity assays were performed. Nitric oxide and heat shock protein 70
(HSP70) production was assessed in target cells. Under hypoxic conditions
enhanced ICAM-1 production was found in both cell types. This resulted in
an increase of adherent neutrophils to AEC and RPAEC. The death rate of
hypoxia-exposed target cells decreased significantly in comparison to control
cells. Nitric oxide (NO) concentration was enhanced, as was production of
HSP70 in AEC. Blocking NO production in target cells resulted in increased
cytotoxicity in AEC and RPAEC. This study shows for the first time that target
cells are more resistant to effector cells under hypoxia, suggesting hypoxia-
induced cell protection. An underlying mechanism for this phenomenon
might be the protective effect of increased levels of NO in target cells.
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Introduction
Alveolar hypoxia might occur under various conditions such
as hypobaric environment (high altitude), hypoventilation
due to cerebral injury, intoxication or obstructive airway
disease. All such situations of reduced oxygen supply are
supposed to play a major role in the development of epithe-
lial lung damage, which in turn is promoting acute lung
injury (ALI) and its progression to acute respiratory distress
syndrome (ARDS) [1]. In ALI as well as in ARDS not only
lung epithelial but also lung vascular endothelial cells are
grossly exposed to reduced oxygen partial pressure.
In the pathogenesis of acute lung inflammation, up-
regulation of inflammatory mediators is essential, driving
various biological effects such as recruiting effector cells
(neutrophils, alveolar macrophages) and initiating adhesion
of effector to target cells [2–4]. Among these mediators the
intercellular adhesion molecule-1 (ICAM-1) seems to play
an essential role [5]. The interaction of neutrophils with
alveolar epithelial cells (AEC) or rat pulmonary artery
endothelial cells (RPAEC) is considered to be a critical step
[6]. It triggers tissue destruction by inducing target cell death
through toxic oxygen products (O2–, H2O2), generated in
effector cells [7,8].
Physiologically, the lung consists of the respiratory (air)
compartment with epithelial cells and the vascular (blood)
compartment is formed mainly by endothelial cells. It is
of major interest whether the different cell populations
perform similarly, and therefore support the inflammatory
response. Although the adhesive interactions between white
blood cells and endothelial or epithelial cells in the vascular
or airway compartment, mediated by adhesion molecules,
have been studied intensively during the past few years, the
mechanisms of this interaction under hypoxia are still not
well understood [9,10].
Nitric oxide (NO) is an important modulator of physi-
ological and pathophysiological processes. Studies investi-
gating the role of NO in the lung often report contradictory
effects ranging from harmful to protective [11,12]. A recent
study showed that hypoxia increased NO production in
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cardiac endothelial cells and cardiomyocytes, but did not
elucidate the biological consequence of this phenomenon
[13].
With knowledge of the results from previous studies per-
formed in the endotoxin-induced cell injury model we pos-
tulated that in hypoxic conditions neutrophils would impair
target cell function through enhanced interaction, leading
finally to increased target cell death [14]. A better under-
standing of the inflammatory mechanisms following
hypoxia might reveal new perspectives regarding possible
therapeutic strategies.
Materials and methods
Alveolar epithelial cells (AEC)
The L2 cell line (CCL 149, American Type Culture Collec-
tion, Rockville, MD, USA) was derived through cloning of
adult female rat lung of alveolar epithelial cell type II origin
[15]. The cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Life Technologies, Basel, Switzerland),
supplemented with 10% fetal bovine serum (FBS), 1%
penicillin–streptomycin and 1% HEPES buffer. Prior to cell
stimulation, the medium was changed to DMEM/1% FBS.
Rat pulmonary artery endothelial cells (RPAEC)
RPAEC, kindly provided by Dr Roscoe Warner PhD,
(Department of Pathology, University of Michigan, Ann
Arbor, MI, USA), were cultured in DMEM, supplemented
with 10% FBS, 1% penicillin and 1% HEPES. At this point
the medium was changed to DMEM/1% FBS.
Hypoxia
A cell incubator (Bioblock, Ittigen, Switzerland) adjustable
to different oxygen concentrations by insufflation of nitro-
gen (N2) was used as a hypoxic cell chamber. The concentra-
tions were monitored continuously by an oxygen sensor.
Experiments were performed with 5% oxygen and 5% CO2
at 37°C. For control cells, an incubator (Bioblock) with 21%
O2, 5% CO2 at 37°C was used. For RNA studies, cells were
grown in 35-mm dishes, for adherence as well as for cyto-
toxicity assays in 96-well tissue culture plates (both from
Corning, New York, NY, USA).
Cells were exposed to 5% O2 for 2, 4 and 6 h, depending
on the assay being performed.
RNA extraction and reverse transcriptase–polymerase
chain reaction (RT–PCR) analysis
Total RNA from AEC and RPAEC was extracted immediately
after exposure using Trizol® (Life Technologies), as described
previously, and mRNA for ICAM-1 was determined [16].
RT–PCR was performed using a PCR core kit (Applied
Biosystems, Rotkreuz, Switzerland). Random hexanucleotide
primers and murine leukaemia virus reverse transcriptase
were used for cDNA synthesis. Reverse transcription was
performed with 0·8 mg of RNA at 20°C for 5 min, 42°C for
30 min and 99°C for 5 min. Primers located on separate
exons were designed to assess ICAM-1 mRNA expression as
follows: sense 5′-AGG TAT CCA TCC ATC CCA CA-3′; anti-
sense 5′-CTT CAG AGG CAG GAA ACA GG-3′. For the
primer pair, optimal cycling conditions were tested to detect
target genes within the logarithmic amplification phase (30
cycles at 58°C). 18S was chosen as housekeeping gene as it
does not modulate upon stimulation with hypoxia [16].
RT–PCR products were resolved on 1·5% agarose gels
(Ultra Pure, Invitrogen, Basel, Switzerland) and stained with
ethidium bromide.
Isolation of neutrophils
Human neutrophils (PMN) were isolated by gradient
centrifugation over Ficoll-Paque (Amersham Pharmacia
Biotech, Dubendorf, Switzerland) followed by 1% dextran
sedimentation for 1 h to separate neutrophils from erythro-
cytes, as described previously [17]. After centrifugation of
the supernatant, contaminating erythrocytes were lysed with
distilled water followed by the addition of 2·7% NaCl to stop
hypotonic lysis. Neutrophils were washed with phosphate-
buffered saline (PBS) and resuspended at a total concentra-
tion of 1 ¥ 106 PMN/ml in DMEM/1% FBS.
Adherence assay
To remain consistent with previous investigations, experi-
ments were performed with human neutrophils [1]. AEC
and RPAEC in 96-well plates were exposed to 2, 4 or 6 h of
hypoxia (5% O2, 5% CO2) or normoxia as controls. Super-
natants were removed and cells were washed once with PBS.
PMN, 2 ¥ 105, were added to each well and incubated for
30 min at 37°C. Wells were washed twice carefully with warm
DMEM and adherent cells were counted.
Cytotoxicity assay
Effector cell-induced cytotoxicity was determined using a
non-radioactive standard lactate dehydrogenase (LDH)
assay (Promega, Madison, WI, USA) [6]. AEC and RPAEC
were cultured in 96-well plates. Neutrophils, 2 ¥ 105, were
added and stimulated with phorbol 12-myristate 13-acetate
(PMA) (Sigma, Buchs, Switzerland) (25 ng/ml final concen-
tration) 15 min later. For control wells without PMN, PMA
was also added to the medium. To study the behaviour of
effector cells at the same time, neutrophils were also placed
into 96-well plates without target cells (effector spontaneous
LDH release). Target and effector cells were exposed with or
without co-incubation to hypoxia or normoxia for 2, 4 and
6 h. LDH in supernatants from target cells in co-culture with
Hypoxia and acute lung injury
359© 2007 British Society for Immunology, Clinical and Experimental Immunology, 150: 358–367
neutrophils was determined as experimental LDH release.
Some AEC and RPAEC were incubated with a lysing solution
(1% Triton-X) for 45 min (target maximum LDH release).
Supernatant fluids were also collected from wells of target
cells, which were not incubated with neutrophils (target
spontaneous LDH release). Cytotoxicity was calculated
according to the following formula: cytotoxicity (%) =
(experimental release - effector spontaneous release - target
spontaneous release)/(target maximum release - target
spontaneous release) ¥ 100.
Measurement of NO production
For measurement of NO, 10 mM 4,5-diaminofluorescein-2/
diacetate (DAF-2/DA) (Calbiochem, Merck, Darmstadt,
Germany) was administered at the end of 2, 4 and 6 h of
hypoxia/normoxia for 30 min. Cells were washed once with
1% DMEM and fluorescence was determined at excitation
and emission wavelengths of 485 and 538 nm, respectively.
NO blocking studies
To assess the role of NO during hypoxia, NW-nitro-L-
arginine methyl ester (L-NAME), a non-selective inhibitor of
nitric oxide synthase (NOS) (Sigma-Aldrich, Steinheim,
Germany), was administered to the samples at a final con-
centration of 10, 25, 50 and 100 mM; 30 min later neutro-
phils were added with PMA as described. Cells were exposed
to 5% O2 for 4 h; control cells remained incubated at 21%
O2. Blocking effect was evaluated focusing on target cell
killing.
Time–course experiments were performed with 50 mM
L-NAME.
Western blot analysis of heat shock protein 70 (HSP70)
L2 and RPAEC from hypoxia and control experiments were
washed with PBS, harvested and lysed in the following
buffer: 10 mM Tris pH 7·4, 5 mM MgCl2, 1 mM phenylm-
ethylsulphonyl fluoride (PMSF), 10 mg/ml protease inhibitor
mix, 100 mg/ml RNAse. Protein content of cell lysates was
determined by a protein assay kit (Bio-Rad, Hercules, CA,
USA). Aliquots containing 10 mg of proteins were separated
on 7·5% sodium dodecyl sulphate-polyacrylamide gel at
50 mA. Proteins were then transferred electrophoretically for
2 h at 200 mA to a nitrocellulose membrane (Bio-Rad).
Equal loading was confirmed by Ponceau S staining. The blot
was washed in PBS and non-specific protein binding on
nitrocellulose membranes was blocked with PBS/4% low fat
milk/0·1% Tween 20 for 1 h at room temperature, followed
by an overnight incubation at 4°C with a 1:1000 dilution of
an anti-HSP70 monoclonal antibody (Invitrogen, San Fran-
cisco, CA, USA) in blocking buffer. All washing steps were
performed three times with PBS/0·1% Tween 20. A second-
ary horseradish peroxidase-labelled goat anti-mouse IgG
(Sigma) diluted 1 : 5000 in blocking buffer was added for 1 h
at room temperature. Signals were detected by enhanced
chemiluminescence.
Statistical analysis
Results are expressed as means standard error of the mean
(s.e.m.). All experiments were conducted at least five times.
Analysis of variance (anova) with post-anova comparison
was performed to assess the statistical significance of
differences. Densitometry data are expressed as percentage
values of controls (control 100%). P-values < 0·05 were con-
sidered significant.
Results
ICAM-1 mRNA up-regulation
In a first approach, the influence of hypoxia on ICAM-1
mRNA expression in AEC and RPAEC was determined. Cells
were exposed for 2, 4 and 6 h to 5% oxygen and mRNA
for ICAM-1 was assessed. Figure 1 shows a representative
gel electrophoresis demonstrating increased expression of
ICAM-1 mRNA in AEC (Fig. 1a) and RPAEC (Fig. 1b).
Upon hypoxia the following up-regulations were found in
comparison to controls in AEC: 53% at 2 h (P < 0·05), 99%
at 4 h (P < 0·001) and 97% at 6 h (P < 0·0005). Similar data
were found in RPAEC: 60% increase at 2 h (P < 0·01), 140%
at 4 h (P < 0·001) and 110% at 6 h (P < 0·0005).
Neutrophil adherence
Neutrophil adherence assays were performed in order to
determine the biological relevance of the up-regulated adhe-
sion molecule. To reduce the use of animals all studies were
performed with human neutrophils, as these cells interact
with rat receptors, as shown previously [1,16,17]. These
effector cells were incubated with target cells after exposure
to hypoxia or 21% O2 and adherent cells were counted. On
AEC, cell count per square increased from 4 1 to 10 1
cells at 2 h (P < 0·001), from 12 1 to 36 1 cells at 4 h
(P < 0·0001) and from 15 1 to 64 4 cells at 6 h
(P < 0·0005) (Fig. 2a). For RPAEC the following enhanced
adherence of neutrophils was assessed per square: from
21 2 to 24 1 at 2 h (not significant: n.s.), from 20 1 to
39 4 cells (P < 0·01) at 4 h, and from 29 3 to 68 3 cells
(P < 0·0005) at 6 h (Fig. 2b).
Target cell killing
Based on the hypothesis that increased neutrophil adherence
would lead to a more extended target cell killing, cytotoxicity
assays were performed. LDH values were evaluated for AEC
and RPAEC without a potential LDH interference of
neutrophils. Interestingly, less AEC and RPAEC were killed
S. Meyer et al.
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Fig. 1. Intercellular adhesion molecule-1 (ICAM-1) expression in
alveolar epithelial cells (AEC) (a) and rat pulmonary artery
endothelial cells (RPAEC) (b). AEC or RPAEC were exposed to 5%
oxygen (hypoxia) or 21% oxygen (control, co) for 2, 4 and 6 h. RNA
was extracted and reverse transcriptase–polymerase chain reaction
was performed. Densitometry values are shown as means standard
error of the mean from five different experiments. AEC: *P < 0·05,
**P < 0·001; RPAEC: *P < 0·01, **P < 0·001.
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Fig. 2. Neutrophil adhesion to alveolar epithelial cells (AEC) (a) and
rat pulmonary artery endothelial cells (RPAEC) (b), exposed
previously to 5% oxygen (hypoxia) or 21% oxygen (control, co).
Neutrophils (2 ¥ 105/well) were added to AEC or RPAEC for 30 min.
Non-adherent cells were washed away and adherent cells were
counted. Values are shown as means standard error of the mean
from five different experiments. AEC: *P < 0·001, **P < 0·0005;
RPAEC: *P < 0·01, **P < 0·0005.
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under hypoxia compared to controls: in comparison to
control conditions with 21% oxygen, cytotoxicity decreased
by 55% at 2 h (P < 0·05), by 57% at 4 h (P < 0·01) and by
60% at 6 h (P < 0·0005) (Fig. 3a). Similar data were found
for RPAEC with diminished cytotoxicity under hypoxia
at 4 h (89%, P < 0·0005) and at 6 h (74%, P < 0·005)
(Fig. 3b).
Determination of NO
Several options were tested to find a possible mechanism
explaining reduced target cell killing under hypoxia. In a
first approach, intracellular NO in AEC and RPAEC was
assessed. While in AEC no change in NO could be detected
at 2 h, NO increased from 252 14 to 440 54 arbitrary
unit (au) at 4 h (P < 0·05) and from 384 60 to 947 19
au at 6 h (P < 0·01) (Fig. 4a). For RPAEC, NO expression at
2 h did not differ between control and hypoxia. At 4 h, it
increased from 66 5 au to 133 11 au (P < 0·05) and at
6 h from 122 6 au to 196 1 au (P < 0·01) (Fig. 4b).
Comparing NO production in AEC and RPAEC, a much
higher baseline expression could be found in AEC than in
RPAEC. Similarly, the increase upon hypoxia was more
pronounced in AEC compared to RPAEC.
NO blocking studies
With the hypothesis that increased NO production in target
cells during hypoxia might exert a protective effect regarding
neutrophil-induced cell killing, NO blocking experiments
with different concentrations of L-NAME were performed in
order to evaluate the most efficient concentration. While 10
and 25 mM L-NAME did not change cytotoxicity in AEC
under hypoxic conditions, 50 and 100 M L-NAME signifi-
cantly attenuated the protective effect of NO, increasing
cytotoxicity (both P < 0·05 hypoxia/L-NAME 0 versus
hypoxia/L-NAME 50/100 cytotoxicity) (Fig. 5a). In RPAEC,
treatment with 50 and 100 M L-NAME increased
neutrophil-induced endothelial cell killing during hypoxia as
well (P < 0·05 and P < 0·001 hypoxia/L-NAME 0 versus
hypoxia/L-NAME 50/100 cytotoxicity) (Fig. 5b).
To evaluate further the effect of blocking NO synthesis,
AEC and RPAEC were pretreated with 50 M L-NAME, fol-
lowed by exposure to hypoxia/normoxia for 2, 4 and 6 h in
co-incubation with neutrophils. Cytotoxicity was deter-
mined in AEC showing the following results: at 2 h, no dif-
ference in cytotoxicity could be seen under hypoxia with or
without L-NAME. At 4 h, cytotoxicity increased by 63% in
the presence of L-NAME (P < 0·005) and at 6 h by 24%
(P < 0·05) (Fig. 6a). Neutrophil-induced cytotoxicity in
RPAEC was without any difference under hypoxia with or
without L-NAME, while it increased by 98% at 4 h (P < 0·05)
and by 26% at 6 h (P < 0·01) (Fig. 6b). These results indicate
that the protective effect of NO might be maximal at 4 h of
hypoxia.
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Fig. 3. Alveolar epithelial cell (AEC) (a) and rat pulmonary artery
endothelial cell (RPAEC) (b) killing by activated neutrophils.
Cytotoxicity assay was performed by measuring lactate dehydrogenase
(LDH) release. Neutrophils (2 ¥ 105/well) were added to AEC or
RPAEC, stimulated with phorbol 12-myristate 13-acetate and
co-incubated with target cells in 5% oxygen (hypoxia) or 21% oxygen
(control, co) for 2, 4 and 6 h. Cytotoxicity (%) was calculated based
on total content and spontaneous release of LDH. Values are shown as
means standard error of the mean from five different experiments.
AEC: *P < 0·05, **P < 0·01; RPAEC: *P < 0·005, **P < 0·0005.
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Expression of HSP70
As diminished target cell killing during hypoxia could only
be explained in part by the NO pathway, other potentially
protective mechanisms were evaluated. In AEC HSP70
expression did not differ significantly between control and
hypoxia at 2 h and 4 h, but increased by 797% at 6 h
(P < 0·01) (Fig. 7a). In RPAEC, no difference in HSP70 pro-
duction could be seen (Fig. 7b).
Discussion
This study demonstrates that hypoxia up-regulated ICAM-1
expression in both AEC and RPAEC, inducing enhanced
neutrophil adhesiveness. Interestingly, target cell killing was
diminished under hypoxia compared to control conditions,
whereby NO, produced in hypoxia-exposed target cells,
might be a protective substance.
ICAM-1, an adhesion molecule of the immunoglobulin
superfamily, seems to be a key mediator in many lung injury
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in alveolar epithelial cells (AEC) (a) and rat pulmonary artery
endothelial cells (RPAEC) (b). Cells were exposed to 5% oxygen
(hypoxia) or 21% oxygen (control) for 2, 4 and 6 h, and were loaded
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1% Dulbecco’s modified Eagle’s medium fluorescence was measured
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from five different experiments. AEC: *P < 0·05, **P < 0·01; RPAEC:
*P < 0·05, **P < 0·01.
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Cytotoxicity (%) was calculated based on total content and
spontaneous release of lactate dehydrogenase (LDH). Values are
shown as means standard error of the mean from five different
experiments. AEC: *P < 0·05; RPAEC: *P < 0·05, **P < 0·001.
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models [18–20]. In our studies, although not demonstrated
directly, ICAM-1 is involved in mediating leucocyte adhe-
sion to AEC and RPAEC in hypoxia. Other cell surface
molecules, such as vascular cell adhesion molecules or
endothelial leucocyte adhesion molecules, are not involved
in the adherence process of PMN (data not shown) [18–20].
In previous studies hypoxia alone did not up-regulate
ICAM-1 expression as demonstrated in human umbilical
vein endothelial cells by Zund et al. [21]. These contradic-
tory results could be due to the fact that different endothelial
cells were used. Previous data from our group, focusing on
primary culture of AEC, underline these data, although
those studies have been performed at very early time-points
of hypoxia [1].
It is expected that increased expression of adhesion mol-
ecules leads to enhanced neutrophil adherence. However, the
result that target cell killing was decreased despite increased
adhesion was striking and is not in accordance with our
hypothesis or with other studies, underlining the role of
PMN in mediating hypoxic injury [22]. Injury to target cells
can be ascribed to a complex array of mediators generated
and released from activated phagocytes. One of the primary
sources of tissue injury are phagocyte-derived substances:
reactive oxygen metabolites and proteases [23]. Phagocytic
cells can be stimulated with chemoattractants, cytokines and
bacterial lipopolysaccharide (LPS). Interaction of any of
these stimuli with specific receptors on the cell surface acti-
vates effector cells which, in turn, generate inflammatory
mediators, phagocyte particles, secrete cytoplasmic granules
and produce oxygen metabolites [24].
While the effect of reactive oxygen species is a well-known
injury-mediating step, the role of NO remains uncertain. In
many models NO has been shown to act as an aggressor,
inducing cell injury [25,26]. Studies involving the use of
mice deficient in specific NOS isoforms have shed some light
on the role of NO in inflammation. In mice lacking endot-
helial NOS (eNOS), basal leucocyte rolling and adhesion
were elevated in mesenteric post-capillary venules, postulat-
ing a possible role for NO in attenuating the inflammatory
response [27]. Data from a study focusing on ALI in induc-
ible NOS (iNOS)–/– mice indicated that absence of iNOS
causes enhanced injury [28]. This finding can be supported
by numerous studies in which pharmacological inhibition of
NOS production provoked a significant increase in adherent
leucocytes [29–31]. Also our data imply a protective role of
NO in the model of acute hypoxia: application of L-NAME
clearly increased the rate of neutrophil-induced cytotoxicity
in AEC and RPAEC. Interestingly, the level of NO produc-
tion in AEC was significantly higher than in RPAEC in this
model of injury. The physiological meaning of this observa-
tion has to be determined. Similar data were obtained
comparing cardiac microvessel endothelial cells and
cardiomyocytes [13].
To define further a potential pathway by which target cells
under hypoxia are more resistant to activated effector cells
than control cells, HSP70 was determined. The HSP70 family
is a group of proteins that plays a crucial role in protein
assembly, folding and transport [32]. Expression of these
proteins after injury can induce ‘stress tolerance’ and protect
(a)
AEC
control
Hypoxia
HSP 70
time (h)
+
–
+
–
+
–
–
+
–
+
–
+
2 2 4 4 6 6
*
300
250
200
150
100
D
en
si
to
m
et
ry
 (
au
)
50
0
co hypoxia
2 h
co hypoxia
4 h
co hypoxia
6 h
(b)
RPAEC
control
Hypoxia
HSP 70
time (h)
+
–
+
–
+
–
–
+
–
+
–
+
2 2 4 4 6 6
300
250
200
150
100
D
en
si
to
m
et
ry
 (
au
)
50
0
co hypoxia
2 h
co hypoxia
4 h
co hypoxia
6 h
Fig. 7. Expression of heat shock protein 70 (HSP70) in alveolar
epithelial cell (AEC) (a) and rat pulmonary artery endothelial cells
(RPAEC) (b) after exposure to 5% oxygen (hypoxia) or 21% oxygen
(control, co) for 2, 4 and 6 h. Cells were lysed and Western blot
analysis was performed (one blot shown). Values are shown as
means standard error of the mean from three different
experiments. AEC: *P < 0·01.
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against a stress that otherwise would be lethal. Previous data
have shown that the induction of the heat stress response via
HSP70 can provide significant protection against many
forms of cellular injury, ischaemia and reperfusion [33,34],
acute lung injury [35–37] and sepsis and septic shock [38].
We therefore postulated that HSP70 might also play a certain
role in the hypoxia-induced cell injury. While HSP70 was
up-regulated at 6 h in AEC, no difference in expression could
be seen in RPAEC.
In summary, the results of our study demonstrate that,
under hypoxia, rat AEC and RPAEC are more robust against
effector-cell induced injury than control cells. One possible
explanation for this phenomenon is the enhanced NO pro-
duction in target cells, as well as increased HSP70 expression
in AEC. To shed further light on the role of NO in this injury
model, in vivo studies are necessary.
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